skip to primary navigationskip to content
 

Dr Andrew McKenzie- Congratulations to our new Royal Society Fellow

last modified May 05, 2017 05:14 PM
Dr Andrew McKenzie FMedSci FRS Fellow Elected: 2017

Andrew McKenzie investigates how the innate and adaptive arms of the immune system protect the body from infection, but can also lead to inappropriate inflammation and pathology.  He has defined and characterised how cytokine networks orchestrate the cellular response to pathogens and how dysregulation of these regulatory pathways can lead to diseases such as asthma and allergy.

His identification of the cytokine interleukin-13 and the subsequent unearthing of its central role in allergic asthma led to his discovery of type-2 innate lymphoid cells (ILC2).  These cells secrete large quantities of cytokines and represent a new therapeutic target for intervention in inflammation and infection.

Andrew was elected as a Fellow of the Academy of Medical Sciences in 2011.

Upcoming events

Antibody Technologies and Therapeutics Conference

Sep 10, 2017

Monash University Conference Centre Prato , Italy

Exploring Human Host-Microbiome Interactions in Health and Disease

Sep 13, 2017

Wellcome Conference Centre, Hinxton

Entrepreneurs in Clinical Academia (ECA) course

Oct 16, 2017

INSEAD, Fontainebleau, France

Upcoming events

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2018.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more